Suchergebnisse - "Milla, Carlos"

PubPharm (15)

1

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis : A Clinical Trial

enthalten in: American journal of respiratory and critical care medicine | 2022

von Nichols, D. | Paynter, A. | Heltshe, S. | +121

CommentIn: Am J Respir Crit Care Med. 2022 Mar 1;205(5):487-489. - PMID 35073504

2

Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND) : an open-label extension study

enthalten in: The Lancet. Respiratory medicine | 2021

von Flume, P. | Biner, R. | Downey, D. | +118

ErratumIn: Lancet Respir Med. 2021 Apr;9(4):e38. - PMID 33636124

3

Long-term safety and efficacy of lumacaftor-ivacaftor therapy in children aged 6-11 years with cystic fibrosis homozygous for the F508del-CFTR mutation : a phase 3, open-label, extension study

enthalten in: The Lancet. Respiratory medicine | 2021

von Chilvers, M. | Davies, J. | Milla, C. | +5

ErratumIn: Lancet Respir Med. 2021 Apr;9(4):e38. - PMID 33607008

4

Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults

enthalten in: Scientific reports | 2018

von Kim, J. | Farahmand, M. | Dunn, C. | +5

5

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL) : a phase 3 single-arm study

enthalten in: The Lancet. Respiratory medicine | 2018

von Rosenfeld, M. | Wainwright, C. | Higgins, M. | +38

CommentIn: Lancet Respir Med. 2018 Jul;6(7):483-484. - PMID 29886025

6

Ivacaftor restores CFTR-dependent sweat gland fluid secretion in cystic fibrosis subjects with S945L alleles

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2018

von Kim, J. | Davies, Z. | Dunn, C. | +2

7

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2017

von Ratjen, F. | Hug, C. | Marigowda, G. | +62

CommentIn: Lancet Respir Med. 2017 Jul;5(7):536-537. - PMID 28606619

8

Lumacaftor/Ivacaftor in Patients Aged 6-11 Years with Cystic Fibrosis and Homozygous for F508del-CFTR

enthalten in: American journal of respiratory and critical care medicine | 2017

von Milla, C. | Ratjen, F. | Marigowda, G. | +4

CommentIn: Am J Respir Crit Care Med. 2017 Apr 1;195(7):849-850. - PMID 28362199

9

The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels : Human in vivo measurements

enthalten in: PloS one | 2017

von Char, J. | Dunn, C. | Davies, Z. | +3

10

Recent advances in cystic fibrosis

enthalten in: Current opinion in pediatrics | 2015

von Milla, C. | Moss, R.